FR2552323A1 - Organic cancericidal substances and method for extracting them - Google Patents

Organic cancericidal substances and method for extracting them Download PDF

Info

Publication number
FR2552323A1
FR2552323A1 FR8315289A FR8315289A FR2552323A1 FR 2552323 A1 FR2552323 A1 FR 2552323A1 FR 8315289 A FR8315289 A FR 8315289A FR 8315289 A FR8315289 A FR 8315289A FR 2552323 A1 FR2552323 A1 FR 2552323A1
Authority
FR
France
Prior art keywords
substances
organic
cancericidal
extracting
cold
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR8315289A
Other languages
French (fr)
Other versions
FR2552323B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IONESCU PANTELIMON DUMITRU
Original Assignee
IONESCU PANTELIMON DUMITRU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IONESCU PANTELIMON DUMITRU filed Critical IONESCU PANTELIMON DUMITRU
Priority to FR8315289A priority Critical patent/FR2552323A1/en
Publication of FR2552323A1 publication Critical patent/FR2552323A1/en
Application granted granted Critical
Publication of FR2552323B1 publication Critical patent/FR2552323B1/fr
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to non radioactive antiflux-bioextinctive organic substances; a method for extracting them from plant and animal tissues by fermentation of these tissues, in the presence of titanium metal, by degassing and purifying their fluxes under vacuum, with the use of heat, and by packaging them under an argon atmosphere, in gelatine capsules or in bottles; and to a method for the prevention and treatment of cancer, of diseases associated with it and of other serious diseases, which method consists in introducing the cancericidal substances into the organism via known routes, inappropriate amounts, under medical supervision.

Description

L'invention présente se réfère à des substances organiques décancérisantes,à un procédé pour leur extraction et à une méthode de décancdrisation.  The present invention relates to decancerising organic substances, to a process for their extraction and to a method of decancdrization.

On connatt de différentes substances chimiques qui poursuivent le traitement du cancer par la destruction de la cellule malade (cancéreuse). Ges substances présentent les désavantages suivants:elles ne sont pas efficaces dans tous les cas,par leur composition chimique elles sont toxiques et par la destruction de la cellule cancéreuse mettent en liberté les composants cancérigènes de la cellule cancéreuse en favorisant leur diffusion dans l'organisme, fait qui produit l'apparition des métastases.  We know of various chemical substances which continue the treatment of cancer by the destruction of the diseased (cancerous) cell. These substances have the following disadvantages: they are not effective in all cases, by their chemical composition they are toxic and by the destruction of the cancer cell release the carcinogenic components of the cancer cell by promoting their diffusion in the body , a fact which produces the appearance of metastases.

Cette invention écarte ces désavantages,par cela que dans le but de prévenir la cancérisation et dans le but de décancé- riser la cellule par sa pacification (refr@idissement), utilise des substances organiques décancérisantes composes par dtanti- fondants-bioextinoteurs froids,extraits des tissus végétaux et animaux par le procédé conforme à l'invention, qui consiste en cela qu'on broie de différents tissus végétaux et animaux, on les décompose par fermentation dans d'eau distillée, jusqu'à des dimensions colloïdales, dans des récipients de titan,des vases émaillés,des vases en verre ou plastique,tous prévus à l'lntéri- eur aveo des oppeaux de titan métallique,on les epure de ses gaz (dégazer) et de ses substances fondantes,en vide au chaud,à des températures convenables contenues entre 50-1600C,après quoi le résidu (les antifondanta-bioextincteurs froids) est broyé et emballé en atmosp@ère d'argon,en capsules de gélatine ou fioles. This invention eliminates these disadvantages, by the fact that in order to prevent cancerization and in order to decancerize the cell by its pacification (refr @ idissement), uses decancérisantes organic substances composed by cold decantants-bioextinoteurs, extracts plant and animal tissues by the process according to the invention, which consists in grinding different plant and animal tissues, they are decomposed by fermentation in distilled water, to colloidal dimensions, in containers of titan, enamelled vases, glass or plastic vases, all intended for interior use with metallic titan oppels, they are purified from its gases (degas) and its melting substances, in hot vacuum, at suitable temperatures contained between 50-1600C, after which the residue (cold antifondanta-bioextinguishers) is crushed and packaged in an atmosphere of argon, in gelatin capsules or vials.

La méthode de écancérisetion,oonformément à l'invetion, consiste en cela qu'd l'aide des substancès organiques décancé- risantes (froides, antifondantes, bioert@ctrices), obtenues par le procédé décrit plus haut,et introduites par voies connues, dans l'organe ou organisme malade@sous contre médical,elle obtient le ré?roidissement des cellules malades (cancéreuses) et ainsi la décancérisation. The method of ecancérisetion, according to the invention, consists of the fact that with the help of the organic decanchanizing substances (cold, antifondant, bioert @ ctrices), obtained by the process described above, and introduced by known routes, in the sick organ or organism @ under counter medical, it obtains the re? roidissement of the sick cells (cancerous) and thus the decancérisation.

En continuation on donne un exemple de la réalisation de l'invention.  In continuation an example of the embodiment of the invention is given.

On broie des tissus organiques,végétaux ou animaux et on les décompose par fermentation en eau distillée jusqu'à des dimensions colloïdales, dans des récipients de titan,des réci- pients émaillés,en verre ou en plsstique,prévus à l'intéri- eur avec des copeaux de titan métallique, on épure de ses gaz (dégazer) et de ses substances fondantes,en vide au chaud,à des températures convenables contenues entre 50-160 C, eprès quoi le résidu se broie et s'emballe en atmosphère d'argon, en capsules de gélatine ou en fioles. Organic, plant or animal tissues are ground and decomposed by fermentation in distilled water to colloidal dimensions, in titan vessels, enamelled containers, made of glass or plastic, provided inside. with metal titan shavings, its gases (degassing) and its melting substances are purified, in a warm vacuum, at suitable temperatures contained between 50-160 ° C., after which the residue grinds and gets carried away in an atmosphere of 'argon, in gelatin capsules or in vials.

Pour la décancérisation des cellules, on introduit par des voies connues, les substanoes crganiques décancérisantes (froides, antifondantes-bioextinctrices) décrites plus haut,dans l'organe ou l'organisme malade, en quantités convenables sous contrôle médical. For the decancerization of cells, we introduce by known routes, the decancerous crganic substanoes (cold, antifondants-bioextinctrices) described above, in the organ or the sick organism, in suitable quantities under medical supervision.

Les substances organiques décanoérisantes,le procédé pour leur extraction et la méthode de décancérisation selon l'in vention, @ont particulierement destinés à la prévention et au traitement du cancer, de @ses maladies associées et d'autres graves maladies.  The decanoerizing organic substances, the process for their extraction and the method of decanceration according to the invention, are particularly intended for the prevention and treatment of cancer, of its associated diseases and of other serious diseases.

Claims (1)

REVENDICATI0N  CLAIM Substances organiques décancérisantes caractérisées en ce qu'elles sont composées de substances organiques froides (antifondants-bioextincteurs) obtenues par broyage de différents tissus végétaux et animaux, on les décompose par fermentation dans l'eau distillée jusqu'à des dimensions colloidales,dans des récipients de titane,des vases émaillés, des vases en verre ou plastique prévus à l'intérieur avec des copeaux de titane métallique,on les épure de leurs gaz (dégazer) et de leurs substances fondantes,chaudes,on vide à chaud,à des températures convenables comprises entre 50-1600C,après quoi le résidu riche en antifondants organi ques,froids,bioextincteurs,est broyé et emballé en atmosphère d'argon,en capsules de gélatine ou en fioles.  Decancering organic substances characterized in that they are composed of cold organic substances (antifondants-bioextinguishers) obtained by grinding different plant and animal tissues, they are decomposed by fermentation in distilled water to colloidal dimensions, in containers of titanium, enamelled vases, glass or plastic vases provided inside with metal titanium shavings, they are purified from their gases (degas) and from their melting substances, hot, they are emptied hot, at temperatures suitable between 50-1600C, after which the residue rich in organic antifondants, cold, bio-extinguishers, is ground and packaged in an argon atmosphere, in gelatin capsules or in vials.
FR8315289A 1983-09-23 1983-09-23 Organic cancericidal substances and method for extracting them Granted FR2552323A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR8315289A FR2552323A1 (en) 1983-09-23 1983-09-23 Organic cancericidal substances and method for extracting them

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8315289A FR2552323A1 (en) 1983-09-23 1983-09-23 Organic cancericidal substances and method for extracting them

Publications (2)

Publication Number Publication Date
FR2552323A1 true FR2552323A1 (en) 1985-03-29
FR2552323B1 FR2552323B1 (en) 1986-01-24

Family

ID=9292550

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8315289A Granted FR2552323A1 (en) 1983-09-23 1983-09-23 Organic cancericidal substances and method for extracting them

Country Status (1)

Country Link
FR (1) FR2552323A1 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2181507A1 (en) * 1972-04-26 1973-12-07 Boutroux Andre Animal and vegetable proteolysates prepn - for treatment of undernutrition

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2181507A1 (en) * 1972-04-26 1973-12-07 Boutroux Andre Animal and vegetable proteolysates prepn - for treatment of undernutrition

Also Published As

Publication number Publication date
FR2552323B1 (en) 1986-01-24

Similar Documents

Publication Publication Date Title
EP0237150B1 (en) Improved radionuclide antibody coupling
EP0341103B1 (en) Method for stabilizing solutions of human albumin, and solution so obtained
US7329421B2 (en) Process of manufacturing clear juice from the leaves of the Aloe vera plant
BE902841A (en) PROCESS FOR IMPROVING THE HANDLING PROPERTIES OF A TANTALUS FLAKE POWDER COMPOSITION
CA1341114C (en) Pharmaceutical formulations containing melphalan hydrochloride
HU176142B (en) Process for separating purified albumine from blood
FR2552323A1 (en) Organic cancericidal substances and method for extracting them
RU2119352C1 (en) Conjugate of antimelanoma antibody and cytotoxic agent and a method of melanoma inhibition
FR2488695A1 (en) PROCESS AND KIT FOR MARKING RED GLOBLES WITH TECHNETIUM-99M
Daniels et al. Photochemical DNA cleavage by the antitumor agent 3-amino-1, 2, 4-benzotriazine 1, 4-dioxide (tirapazamine, WIN 59075, SR4233)
Lunde Location of lipid‐soluble selenium in marine fish to the lipoproteins
US4228146A (en) Method of producing radioactive carbon powder
Elderfield et al. Synthesis of Potential Anticancer Agents. XV. Nitrogen Mustards from Indole Derivatives1, 2
Eckelman et al. High-specific-activity 99mTc human serum albumin
US4412987A (en) Addition agent for medicines or cosmetics
Brookes Studies on the incorporation of an unnatural amino acid, p-di-(2-hydroxy [14C2] ethyl) amino-L-phenylalanine, into proteins
JPS6122021A (en) Antitumor polysaccharide nrp-1 and preparation thereof
FR2613620A1 (en) Implant intended for human medicine
Laswick et al. Caffeine and benzoic acid in soft drinks
Cerrato Can plant estrogens help fight cancer?
RU2255766C2 (en) Method for preparing immunoglobulin preparation for prophylaxis and therapy of bacterial and viral infection, immunoglobulin preparation for prophylaxis and therapy of bacterial and viral infection (variants) and suppository based on immunoglobulin preparation
Grabar The “globulines-transporteurs” theory and auto-sensitization
Sud et al. UNDERPINNING THE CLASSICAL PREPARATION RASAKARPURA (MERCURIAL SALT)-A REVIEW
GB1005393A (en) Improvements in or relating to refractory uranium compounds
JPS62169800A (en) Protein derivative and its production

Legal Events

Date Code Title Description
ST Notification of lapse